Literature DB >> 12969172

On-line mixed hemodiafiltration with a feedback for ultrafiltration control: effect on middle-molecule removal.

Luciano A Pedrini1, Vincenzo De Cristofaro.   

Abstract

BACKGROUND: Increased middle-molecular uremic toxin removal seems to favorably influence survival in dialysis patients. The aim of this study was to verify if, in on-line mixed hemodiafiltration, solute removal by convection may be enhanced by forcing the ultrafiltration rate (QUF) and optimizing the infusion technique in order to achieve the highest possible filtration fraction (FF).
METHODS: Removal of beta2-microglobulin (beta2-m), urea, creatinine, and phosphate were compared in 20 patients randomly submitted to one dialysis session (A), one postdilution hemodiafiltration session (B), and three sessions of mixed hemodiafiltration (C, D, and E) at different infusion rates (QS). In mixed hemodiafiltration, a newly developed feedback system automatically maintained the transmembrane pressure (TMP) within its highest range of safety (250 to 300 mm Hg) at constant QUF, while ensuring the maximum FF by splitting infusion between pre- and postdilution.
RESULTS: A mean QS of 134 +/- 20 mL/min (mean FF = 0.65) was attained in post-HDF, and up to 307 +/- 41 mL/min (mean FF = 0.69) in mixed hemodiafiltration. The mean dialysate clearances (KDQ) for all tested solutes and urea eKt/V were significantly higher in all hemodiafiltration sessions than in dialysis. Only in the case of urea did the infusion mode have no significant effect. KDQ for beta2-m was maximal in session D and significantly higher than in session B (90.2 +/- 11 mL/min vs. 77.5 +/- 11 mL/min; P = 0.02). KDQ for beta2-m significantly correlated with QS and the plasma water flow rate (QPW). The highest KDQ for beta2-m was found at values of QS approximately QPW. Beyond this value KDQ decreased.
CONCLUSION: The mixed infusion mode in hemodiafiltration, controlled by the TMP-ultrafiltration feedback, seems to improve the efficiency of hemodiafiltration by fully exploiting the convective mechanism of solute removal. The feedback automatically adjusted the infusion rate and site to the maximum FF taking into account flow conditions, internal pressures, and hydraulic permeability of the dialyzer and their complex interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969172     DOI: 10.1046/j.1523-1755.2003.00240.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD.

Authors:  Francesco Locatelli; Paolo Altieri; Simeone Andrulli; Piergiorgio Bolasco; Giovanna Sau; Luciano A Pedrini; Carlo Basile; Salvatore David; Mariano Feriani; Giovanni Montagna; Biagio Raffaele Di Iorio; Bruno Memoli; Raffaella Cravero; Giovanni Battaglia; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

2.  Effect of different dialysis modalities on microinflammatory status and endothelial damage.

Authors:  Ana Merino; José Portolés; Rafael Selgas; Raquel Ojeda; Paula Buendia; Javier Ocaña; M Auxiliadora Bajo; Gloria del Peso; Julia Carracedo; Rafael Ramírez; Alejandro Martín-Malo; Pedro Aljama
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

3.  An experimental and numerical study of the flow and mass transfer in a model of the wearable artificial kidney dialyzer.

Authors:  Edmond Rambod; Masoud Beizai; Moshe Rosenfeld
Journal:  Biomed Eng Online       Date:  2010-05-24       Impact factor: 2.819

4.  Comparison of the effects of predilution and postdilution hemodiafiltration on neutrophils, lymphocytes and platelets.

Authors:  Kenji Sakurai; Takeshi Saito; Fumi Yamauchi; Daiki Asahi; Hiromi Hosoya
Journal:  J Artif Organs       Date:  2013-03-07       Impact factor: 1.731

5.  Haemodiafiltration-optimal efficiency and safety.

Authors:  Ingrid Ledebo; Peter J Blankestijn
Journal:  NDT Plus       Date:  2009-11-05

6.  Clinical outcomes of hemodialysis patients in a public-private partnership care framework in Italy: a retrospective cohort study.

Authors:  L A Pedrini; A C Winter; F Cerino; A M Zawada; M Garbelli; A Feuersenger; A Feliciani; P Ruggiero; S Civardi; C Amato; B Canaud; S Stuard; A Karch; A Gauly
Journal:  BMC Nephrol       Date:  2019-02-01       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.